Literature DB >> 25666099

Skeletal muscle percentage: a protective factor for postoperative morbidity in Crohn's disease patients with severe malnutrition.

Wei Zhang1, Weiming Zhu, Jianan Ren, Lugen Zuo, Xiuwen Wu, Jieshou Li.   

Abstract

BACKGROUND: There are no appropriate variables for predicting postoperative morbidity in Crohn's disease (CD) patients with severe malnutrition. We examined a retrospective cohort to clarify these.
MATERIALS AND METHODS: Between 2005 and 2013, 138 CD patients with severe malnutrition underwent elective intestinal resection after preoperative management, consisting of nutritional support, abscess drainage, intravenous antibiotics, steroids tapering, and infliximab weaning, as appropriate. The severity of postoperative morbidity (within the first 30 days) was examined according to the Clavien-Dindo classification system.
RESULTS: After a median duration of 26 days of preoperative management, Crohn's disease activity index (CDAI) and C-reactive protein (CRP) significantly decreased, and body mass index (BMI), skeletal muscle percentage (SMP), body fat percentage (BFP), albumin, prealbumin, and hemoglobin significantly increased (P < 0.001). Postoperative overall morbidities occurred in 28 (20.3%) patients including 15 (10.8%) major complications (Clavien-Dindo classification ≥ III). In the multivariate logistic regression analysis, preoperative CRP (P = 0.044, OR 1.156, 95% CI 1.004-1.331) was a significantly independent risk factor for overall complications, and preoperative SMP (P = 0.002, OR 0.487, 95% CI 0.307-0.772) and BFP (P = 0.036, OR 0.691, 95% CI 0.490-0.996) were significantly independent protective factors. Notably, only preoperative SMP (P = 0.002, OR 0.588, 95% CI 0.422-0.820) was a significantly independent protective factor for major complications, and our threshold of SMP was 24.3% (P < 0.001, sensitivity 83.7%, specificity 95.9%).
CONCLUSIONS: Preoperative SMP is a protective factor for postoperative overall and major complications in CD patients with severe malnutrition and deserves further study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25666099     DOI: 10.1007/s11605-015-2763-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

1.  Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial.

Authors:  F Bozzetti; C Gavazzi; R Miceli; N Rossi; L Mariani; L Cozzaglio; G Bonfanti; S Piacenza
Journal:  JPEN J Parenter Enteral Nutr       Date:  2000 Jan-Feb       Impact factor: 4.016

2.  Risk factors for intra-abdominal sepsis after surgery in Crohn's disease.

Authors:  T Yamamoto; R N Allan; M R Keighley
Journal:  Dis Colon Rectum       Date:  2000-08       Impact factor: 4.585

Review 3.  Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease.

Authors:  P Zerbib; D Koriche; S Truant; A F Bouras; G Vernier-Massouille; D Seguy; F R Pruvot; A Cortot; J F Colombel
Journal:  Aliment Pharmacol Ther       Date:  2010-05-22       Impact factor: 8.171

4.  Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients.

Authors:  Arnaud Alves; Yves Panis; Yoram Bouhnik; Marc Pocard; Eric Vicaut; Patrice Valleur
Journal:  Dis Colon Rectum       Date:  2007-03       Impact factor: 4.585

5.  Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome.

Authors:  Igors Iesalnieks; Alexandra Kilger; Heidi Glass; Rene Müller-Wille; Frank Klebl; Claudia Ott; Ulrike Strauch; Pompiliu Piso; Hans J Schlitt; Ayman Agha
Journal:  Int J Colorectal Dis       Date:  2008-08-09       Impact factor: 2.571

6.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.

Authors:  A J Greenstein; P Lachman; D B Sachar; J Springhorn; T Heimann; H D Janowitz; A H Aufses
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

7.  Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.

Authors:  Luzia Valentini; Lennart Schaper; Carsten Buning; Susanne Hengstermann; Thomas Koernicke; Wolfgang Tillinger; Francesco William Guglielmi; Kristina Norman; Sabine Buhner; Johann Ockenga; Matthias Pirlich; Herbert Lochs
Journal:  Nutrition       Date:  2008-05-21       Impact factor: 4.008

8.  Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase.

Authors:  Raquel Rocha; Genoile Oliveira Santana; Neogélia Almeida; Andre Castro Lyra
Journal:  Br J Nutr       Date:  2009-03       Impact factor: 3.718

9.  Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure?

Authors:  Lucio Cuoco; Giorgio Vescovo; Roberto Castaman; Barbara Ravara; Giovanni Cammarota; Annalisa Angelini; Mario Salvagnini; Luciano Dalla Libera
Journal:  Int J Cardiol       Date:  2007-08-10       Impact factor: 4.164

10.  Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition.

Authors:  Stefan Jacobson
Journal:  Scand J Gastroenterol       Date:  2012-02       Impact factor: 2.423

View more
  3 in total

Review 1.  Prehabilitation prior to intestinal resection in Crohn's disease patients: An opinion review.

Authors:  Michiel T J Bak; Marit F E Ruiterkamp; Oddeke van Ruler; Marjo J E Campmans-Kuijpers; Bart C Bongers; Nico L U van Meeteren; C Janneke van der Woude; Laurents P S Stassen; Annemarie C de Vries
Journal:  World J Gastroenterol       Date:  2022-06-14       Impact factor: 5.374

Review 2.  Malnutrition: laboratory markers vs nutritional assessment.

Authors:  Shishira Bharadwaj; Shaiva Ginoya; Parul Tandon; Tushar D Gohel; John Guirguis; Hiren Vallabh; Andrea Jevenn; Ibrahim Hanouneh
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-05-11

3.  Systematic review of nutrition screening and assessment in inflammatory bowel disease.

Authors:  Suqing Li; Michael Ney; Tannaz Eslamparast; Ben Vandermeer; Kathleen P Ismond; Karen Kroeker; Brendan Halloran; Maitreyi Raman; Puneeta Tandon
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.